Therapy Areas: Cardiovascular
Flumist Quadrivalent Vaccine Now Available in the US for Annual Flu Season
31 August 2021 - - Flumist Quadrivalent (Influenza Vaccine Live, Intranasal) doses are now available in the US for the 2021-2022 influenza season, British-Swedish pharmaceutical and biotechnology company AstraZeneca (NASDAQ: AZN) said.

Flumist Quadrivalent, the only Food and Drug Administration -approved nasal-spray flu vaccine, is indicated for people ages 2 through 49. The bulk of AstraZeneca's supply for the 2021-2022 flu season is expected to be available by mid-September.

In line with the 2021-2022 recommendations from the CDC's Advisory Committee on Immunization Practices and the American Academy of Pediatrics, Flumist Quadrivalent continues to be an option for flu vaccination in the US this season. Vaccines may not prevent influenza in everyone who gets vaccinated.

The CDC continues to stress the importance of receiving a yearly flu vaccine, citing vaccination as the most effective protection against seasonal flu infection.

Additionally, they reinforce that flu vaccination during the 2021-2022 season will help protect the public against preventable illness, as well as help alleviate burden on the healthcare system.

Since Flumist Quadrivalent is the only FDA-approved flu vaccine to use a needle-free nasal spray administrative technique, it may be preferred by eligible patients.

AstraZeneca's live attenuated influenza vaccine (either as trivalent or quadrivalent formulations) has been approved by the FDA since 2003 and is covered by most health insurance plans.

The most common side effects of Flumist Quadrivalent are runny or stuffy nose, sore throat, and fever over 100°F.

Please note, all available influenza vaccines are manufactured differently and different preparations have different indications as licensed by the FDA. 

Flumist Quadrivalent is a vaccine indicated for active immunization of persons 2-49 years of age for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. Flumist Quadrivalent is for intranasal administration only.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal and Metabolism, and Respiratory and Immunology.

Based in Cambridge, UK, AstraZeneca operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide.